| Reflections on Sandy Hook: a decade later J Sukhera, H Schwartz Academic Psychiatry 47 (5), 486-487, 2023 | 1 | 2023 |
| The Mind of the Mass School Shooter HI Schwartz The Journal of the American Academy of Psychiatry and the Law 51 (3), 314-319, 2023 | | 2023 |
| The association of prescription opioid use with suicide attempts: An analysis of statewide medical claims data C Luo, K Chen, R Doshi, N Rickles, Y Chen, H Schwartz, RH Aseltine PLoS one 17 (6), e0269809, 2022 | 9 | 2022 |
| The Institute of Living: Two Hundred Years of Innovation and Excellence. HI Schwartz Connecticut Medicine 86 (1), 2022 | | 2022 |
| Delusions and Other Forms of Irrational Belief in the Age of QAnon. G Pearlson, HI Schwartz Connecticut Medicine 86 (1), 2022 | 1 | 2022 |
| Harnessing Big Data in Health Care: Challenges in Enhancing the Clinical Utility of Patient Data for Suicide Prevention. R Aseltine, K Chen, F Wang, J Jin, HI Schwartz Connecticut Medicine 86 (1), 2022 | | 2022 |
| Identifying risk factors for mortality among patients previously hospitalized for a suicide attempt RP Doshi, K Chen, F Wang, H Schwartz, A Herzog, RH Aseltine Jr Scientific reports 10 (1), 15223, 2020 | 23 | 2020 |
| Illustrating the role of health information exchange in a learning health system: improving the identification and management of suicide risk. RP DOSHI, FEI WANG, H SCHWARTZ, SC ROGERS, KUN CHEN Connecticut Medicine 82 (6), 2018 | 2 | 2018 |
| 14.1 The Sandy Hook School Shooting: Mentalization Deficits and Mass Murder HI Schwartz Journal of the American Academy of Child & Adolescent Psychiatry 56 (10), S21, 2017 | | 2017 |
| Reduction of seclusion and restraint in an inpatient psychiatric setting: a pilot study EW Blair, S Woolley, BL Szarek, TF Mucha, O Dutka, HI Schwartz, ... Psychiatric Quarterly 88, 1-7, 2017 | 80 | 2017 |
| On naturalistic pharmacogenetic studies: reply from the authors RL Seip, JW Goethe, HI Schwartz, G Ruaño Biomarkers in Medicine 7 (6), 917-918, 2013 | | 2013 |
| Length of Psychiatric Hospitalization is Correlated With CYP2D6 Functional Status in Inpatients with Major Depressive Disorder G Ruaño, BL Szarek, D Villagra, K Gorowski, M Kocherla, RL Seip, ... Biomarkers in medicine 7 (3), 429-439, 2013 | 51 | 2013 |
| Juvenile psychiatry and the law R Rosner, HI Schwartz Springer Science & Business Media, 2012 | 16 | 2012 |
| Validation of candidate genes associated with cardiovascular risk factors in psychiatric patients A Windemuth, J de Leon, JW Goethe, HI Schwartz, S Woolley, M Susce, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 36 (2), 213-219, 2012 | 3 | 2012 |
| Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping of CYP2C9, CYP2C19 and CYP2D6 genes D Villagra, J Goethe, HI Schwartz, B Szarek, M Kocherla, K Gorowski, ... Biomarkers in medicine 5 (4), 427-438, 2011 | 38 | 2011 |
| Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients G Ruaño, D Villagra, B Szarek, A Windemuth, M Kocherla, K Gorowski, ... Biomarkers in medicine 5 (4), 439-449, 2011 | 21 | 2011 |
| Inpatient Care in the 21st Century: Who Needs It?—In Reply ID Glick, SS Sharfstein, HI Schwartz Psychiatric Services 62 (5), 563-564, 2011 | | 2011 |
| Ultrashort stays and a focus on recovery—in reply ID Glick, SS Sharfstein, HI Schwartz Psychiatric Services 62 (4), 435-435, 2011 | 2 | 2011 |
| Inpatient psychiatric care in the 21st century: the need for reform ID Glick, SS Sharfstein, HI Schwartz Psychiatric Services 62 (2), 206-209, 2011 | 138 | 2011 |
| Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies. G Ruaño, CL Blair, B Bower, A Windemuth, M Kocherla, Y Aleman, ... Connecticut medicine 71 (4), 197-200, 2007 | 9 | 2007 |
